Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of pyrazoloacridine in treating patients
who have unresectable primary or metastatic kidney cancer that has not been previously
treated.